Intellia Therapeutics(CH:38I)
CHFÂ 9.600.00 (0.00%)
CH:38I
Intellia Therapeutics earnings date
CHFÂ 9.60
At close:0.00 (0.00%)
Intellia Therapeutics (38I) Q2 2024 Earnings Report
0 Followers
CH:38I Q2 2024 EPS Results
- Actual EPS
- -CHF 1.27
- Consensus EPS
- -CHF 1.02
- Beat/Miss
- Missed by -CHF 0.25
- One Year Ago EPS
- -CHF 1.17
CH:38I Q2 2024 Revenue Results
- Actual Revenue
- CHF 5.81M
- Expected Revenue
- CHF 16.44M
- Beat/Miss
- Missed by -CHF 10.62M
- YoY Revenue Growth
- -48.82%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- Before Open
- Conference Call
- Thursday, August 8, 2024
CH:38I Upcoming Earnings
Intellia Therapeutics's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:38I Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:38I Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.66- | -0.69 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.67-0.76 | -0.77 | 1.09% (+0.01) | |
| Aug 06, 2026 | 2026 (Q2) | -0.67-0.67 | -0.82 | 18.37% (+0.15) | |
| May 11, 2026 | 2026 (Q1) | -0.76-0.68 | -0.92 | 26.36% (+0.24) | |
| Feb 26, 2026 | 2025 (Q4) | -0.80-0.69 | -1.06 | 34.65% (+0.37) | |
| Nov 06, 2025 | 2025 (Q3) | -0.84-0.77 | -1.12 | 31.34% (+0.35) | |
| Aug 07, 2025 | 2025 (Q2) | -0.85-0.82 | -1.27 | 35.53% (+0.45) | |
| May 08, 2025 | 2025 (Q1) | -1.07-0.92 | -0.94 | 1.79% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -1.11-1.06 | -1.22 | 13.01% (+0.16) | |
| Nov 07, 2024 | 2024 (Q3) | -1.16-1.12 | -1.15 | 2.90% (+0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

